| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 16,041,861 | 7,914,611 |
| Net increase (decrease) in cash and cash equivalents | -497,944 | -2,413,079 |
| Cash and cash equivalents at beginning of period | 5,506,941 | - |
| Cash and cash equivalents at end of period | 5,008,997 | - |
GeoVax Labs, Inc. (GOVX)
GeoVax Labs, Inc. (GOVX)